Brilinta (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca.
Ticagrelor (Handelsbezeechnung Brilinta an den USA, Brilique a Possia an der EU) ass e Plättchen Aggregatiounsinhibitor vun AstraZeneca.